34229511000001107: Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\UK product\Virtual medicinal product\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\UK product\Virtual therapeutic moiety\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)

\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing podophyllotoxin and/or podophyllotoxin derivative (product)\Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product)\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing podophyllotoxin and/or podophyllotoxin derivative (product)\Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product)\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing mitotic inhibitor\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing podophyllotoxin and/or podophyllotoxin derivative (product)\Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product)\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing podophyllotoxin and/or podophyllotoxin derivative (product)\Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product)\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product)\Product containing etoposide\Etoposide\Etoposide 500mg/25ml solution for injection vials\Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

103787301000001117 Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

103787401000001113 Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Is a	Etoposide 500mg/25ml solution for injection vials	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has active ingredient	Etoposide	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has manufactured dose form	Conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	VMP non-availability indicator	Re-introduced	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has specific active ingredient	Etoposide	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has dispensed dose form	Conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Has excipient	Benzyl alcohol	false	Inferred relationship	Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial	Has AMP	True	Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
103787301000001117	Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
103787401000001113	Etoposide 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module